Get the Stockscreener App
1.80
2.20%
-0.02
After Hours:
1.80
Waldencast Plc stock is traded at $1.80, with a volume of 36,126.
It is down -2.20% in the last 24 hours and up +9.20% over the past month.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
See More
Previous Close:
$1.82
Open:
$1.84
24h Volume:
36,126
Relative Volume:
0.37
Market Cap:
$221.88M
Revenue:
-
Net Income/Loss:
$-11.05M
P/E Ratio:
-6.9124
EPS:
-0.2604
Net Cash Flow:
$2.18M
1W Performance:
+2.30%
1M Performance:
+9.20%
6M Performance:
-5.32%
1Y Performance:
-47.18%
1-Day Range:
$1.765
$1.84
1-Week Range:
$1.66
$1.98
52-Week Range:
$1.45
$3.5399
Waldencast Plc Stock (WALD) Company Profile
Name
Waldencast Plc
Sector
Industry
Phone
(917) 546-6828
Address
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, EL, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.79 | 225.60M | 0 | -11.05M | 2.18M | -0.2604 |
|
PG
Procter Gamble Co
|
161.21 | 371.84B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
73.43 | 160.09B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
96.17 | 76.83B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
106.41 | 38.12B | 14.67B | -178.00M | 1.14B | -0.5002 |
|
KMB
Kimberly Clark Corp
|
108.26 | 35.71B | 17.23B | 1.75B | 1.64B | 6.0654 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-26 | Resumed | Jefferies | Buy |
| Nov-25-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Apr-22-25 | Initiated | Alliance Global Partners | Buy |
| Dec-16-24 | Initiated | TD Cowen | Hold |
| Oct-25-24 | Initiated | Canaccord Genuity | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Waldencast Plc Stock (WALD) Latest News
Waldencast: Strategic Reviews Are More Than Necessary (NASDAQ:WALD) - Seeking Alpha
Growth Review: Can Waldencast plc Equity Warrant outperform in the next rally2025 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn
Dividend Watch: What is the long term forecast for Waldencast plc stockMarket Risk Report & Community Shared Stock Ideas - baoquankhu1.vn
How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes - Yahoo Finance UK
SoCal med spa DermFx to evaluate Obagi MagIQ injectable in daily practice - Stock Titan
Retail Surge: Is Waldencast plc Equity Warrant a strong growth stockMarket Activity Recap & Verified Technical Trade Signals - baoquankhu1.vn
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
Obagi Medical and Moxie Announce Collaboration in the ALOHA - GlobeNewswire
Aug Technicals: Will Waldencast plc benefit from rising consumer demandMarket Risk Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect - GlobeNewswire
New Obagi two-step lip peel aims for smoother, protected lips - Stock Titan
How strong is Waldencast plc Equity Warrant stock revenue growth2025 Major Catalysts & Smart Swing Trading Techniques - mfd.ru
US Market Wrap: Is Waldencast plc Equity Warrant a strong growth stock2025 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Waldencast PLC (NASDAQ:WALD) Short Interest Down 25.7% in January - MarketBeat
VIO Med Spa to test Obagi MagIQ filler in nationwide clinics - Stock Titan
Inside Obagi’s plan to test a new injectable across Next Health wellness centers - Stock Titan
UPDATEObagi Medical and Alpha Aesthetic Partners - GlobeNewswire
Obagi filler to be studied across 31 Alpha medspa locations - stocktitan.net
Published on: 2026-01-27 01:38:51 - baoquankhu1.vn
CORRECTIONObagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
CORRECTION – Obagi Medical and Platinum Dermatology - GlobeNewswire
Obagi Medical and Platinum Dermatology Partners Announce - GlobeNewswire
Platinum’s 120-clinic network to trial Obagi’s new MagIQ injectable - Stock Titan
Waldencast PLC (NASDAQ:WALD) Receives $4.42 Consensus Price Target from Brokerages - Defense World
Can Waldencast plc disrupt its industryWeekly Trend Summary & Reliable Volume Spike Alerts - mfd.ru
Waldencast PLC (NASDAQ:WALD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Obagi Medical Unveils ALOHA Program to Launch Obagi® - GlobeNewswire
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - The Manila Times
Can Waldencast plc Equity Warrant outperform in the next rallyJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - bollywoodhelpline.com
Waldencast PLC (NASDAQ:WALD) Sees Large Drop in Short Interest - MarketBeat
Jefferies Financial Group Begins Coverage on Waldencast (NASDAQ:WALD) - Defense World
Waldencast Shareholders Back Board Slate and Auditor at January 2026 AGM - TipRanks
MACD Signal: Should value investors consider Waldencast plc Equity WarrantProfit Target & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Waldencast (NASDAQ:WALD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Market Review: Why Waldencast plc Equity Warrant stock could outperform in 2025 - Bộ Nội Vụ
Retail Trends: How Waldencast plc Equity Warrant stock valuations compare to rivalsPortfolio Return Report & AI Based Trade Execution Alerts - moha.gov.vn
Entry Recap: Can Waldencast plc be recession proof2025 Market Trends & Weekly Top Gainers Alerts - baoquankhu1.vn
Waldencast plc's (NASDAQ:WALD) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors - simplywall.st
Buy Signal: Is Waldencast plc stock a top pick in earnings season2025 Breakouts & Breakdowns & Consistent Growth Equity Picks - ulpravda.ru
Why Waldencast plc stock is trending among retail traders2025 Key Highlights & Daily Profit Maximizing Tips - Улправда
Will Waldencast plc Equity Warrant stock see insider buying2025 Key Lessons & Technical Pattern Based Buy Signals - Улправда
Can Waldencast plc Equity Warrant stock surprise with earnings upside2025 Retail Activity & Real-Time Volume Spike Alerts - Улправда
Will Waldencast plc Equity Warrant stock reach Wall Street targets2025 Bull vs Bear & Daily Growth Stock Tips - Улправда
How resilient is Waldencast plc Equity Warrant stock in market downturnsJuly 2025 Short Interest & High Return Trade Guides - ulpravda.ru
Will Waldencast plc stock remain a Wall Street favoriteJuly 2025 Technicals & Community Verified Trade Signals - Улправда
Will Waldencast plc stock rally after Fed decisionsJuly 2025 Macro Moves & Technical Confirmation Alerts - Улправда
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plcWALD - Your Wyoming Link
Can Waldencast plc Equity Warrant stock sustain market leadership2025 Support & Resistance & Community Verified Trade Signals - Улправда
Is Waldencast plc Equity Warrant stock resilient to inflationMarket Liquidity Analysis & Daily Tips From Top Market Analysts - ulpravda.ru
Why Waldencast plc stock is popular among millennialsMarket Profile Overview & Free Tremendous Return On Equity - Улправда
Waldencast Plc Stock (WALD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):